Frequently Asked Questions Should BPC 157 be injected intramuscularly or subcutaneously for a tendon injury
You've pushed through pain, managed symptoms, and adapted your life around limitations you never asked for
Provincial drug information services can answer questions about medication interactions and safety concerns, though staff may have limited familiarity with research peptides specifically
BPC-157's wound-healing literature (PMID 34267654) and TB-500's parent dermal-healing literature (PMID 27450738) collectively cover dermal, tendon, ligament, muscle, bone, peripheral-nerve, and vascular tissue categories
For a disulfide-containing synthetic peptide, a stronger analytical package may require orthogonal identity and purity methods, evidence supporting disulfide configuration, impurity profiling, assay or net peptide content, water and counterion determination, residual-solvent testing, and stability-indicating methods